Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300073768Phase 4Recruiting
Phase 4, open-label trial of esketamine (2 arms), sponsored by The Affiliated Hospital of Yangzhou University. Primary endpoints: Arterial blood gas values, Inflammatory factors and 1 more. Started Jan 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300073768.